Ming-Qiang Zhang

Ming-Qiang Zhang has a strong background in medicinal chemistry and extensive experience in various pharmaceutical companies, holding leadership positions such as Vice President, Chief Technology Officer, and Senior VP R&D. Currently serving as the Vice President of Research & Development at Amgen, Ming-Qiang Zhang has also worked at companies such as Merck Sharp & Dohme, Hoffmann-La Roche, and Shire Pharmaceuticals. Ming-Qiang Zhang's educational background includes a BSc in Medicinal Chemistry from China Pharmaceutical University, a PhD in Medicinal Chemistry from the University of Antwerp, and a post-doc in Medicinal Chemistry from Vrije Universiteit Amsterdam.